By Kate Burba
BOSTON — Hispanic and Asian patients with metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma were less likely to undergo liver transplantation compared with other races and ethnicities, data showed.
“MASH-HCC rates are much higher in our Hispanic patients and have surpassed hepatitis C-related HCC in 2019,” David W. Victor, MD, associate professor of clinical medicine at Houston Methodist Hospital, said at The Liver Meeting. Read the full article in Healio.